Arizona State University's Biodesign Institute said today that it will collaborate with Life Technologies to develop a real-time PCR-based platform to rapidly assess an individual's exposure to radiation in the event of a nuclear incident.

As part of the agreement, researchers from the Biodesign Institute are designing a multi-gene assay panel that would run on real-time PCR systems from Life Tech such as the Applied Biosystems 7500 Fast Dx and QuantStudio Dx, and would identify individuals exposed to abnormal levels of radiation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.